Shaimaa M. Badr-Eldin

3.4k total citations · 1 hit paper
75 papers, 2.3k citations indexed

About

Shaimaa M. Badr-Eldin is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Shaimaa M. Badr-Eldin has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmaceutical Science, 18 papers in Molecular Biology and 12 papers in Biomaterials. Recurrent topics in Shaimaa M. Badr-Eldin's work include Advanced Drug Delivery Systems (18 papers), Drug Solubulity and Delivery Systems (14 papers) and Advancements in Transdermal Drug Delivery (14 papers). Shaimaa M. Badr-Eldin is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Drug Solubulity and Delivery Systems (14 papers) and Advancements in Transdermal Drug Delivery (14 papers). Shaimaa M. Badr-Eldin collaborates with scholars based in Saudi Arabia, Egypt and United States. Shaimaa M. Badr-Eldin's co-authors include Hibah M. Aldawsari, Osama A. A. Ahmed, Mona Hassan Aburahma, Emad B. Basalious, Sabna Kotta, Nabil A. Alhakamy, Anroop B. Nair, Seham A. Elkheshen, Mahmoud M. Ghorab and Tarek A. Ahmed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Food Chemistry.

In The Last Decade

Shaimaa M. Badr-Eldin

73 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study

2021 167 citations Shaimaa M. Badr-Eldin, Basma G. Eid et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaimaa M. Badr-Eldin Saudi Arabia	26	1.0k	489	305	220	218	75	2.3k
Juan J. Torrado Spain	27	848 0.8×	459 0.9×	181 0.6×	239 1.1×	367 1.7×	102	2.6k
Emad B. Basalious Egypt	26	996 1.0×	397 0.8×	214 0.7×	153 0.7×	119 0.5×	58	1.9k
Marina Pinheiro Portugal	25	553 0.6×	755 1.5×	414 1.4×	138 0.6×	135 0.6×	62	2.1k
Ibrahim A. Aljuffali Saudi Arabia	27	620 0.6×	546 1.1×	231 0.8×	215 1.0×	98 0.4×	82	2.2k
Shaila A. Lewis India	26	1.0k 1.0×	473 1.0×	264 0.9×	176 0.8×	72 0.3×	94	2.0k
Mohamed A. El-Nabarawi Egypt	29	2.0k 2.0×	537 1.1×	420 1.4×	311 1.4×	92 0.4×	168	3.1k
Parisa Ghasemiyeh Iran	15	630 0.6×	405 0.8×	342 1.1×	156 0.7×	189 0.9×	39	1.6k
Toshinobu Seki Japan	25	791 0.8×	547 1.1×	296 1.0×	112 0.5×	154 0.7×	112	2.1k
Abdus Samad India	25	572 0.6×	1.1k 2.2×	480 1.6×	157 0.7×	210 1.0×	80	2.6k
Imran Saleem United Kingdom	28	612 0.6×	424 0.9×	354 1.2×	221 1.0×	90 0.4×	67	1.8k

Countries citing papers authored by Shaimaa M. Badr-Eldin

Since Specialization

Citations

This map shows the geographic impact of Shaimaa M. Badr-Eldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaimaa M. Badr-Eldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaimaa M. Badr-Eldin more than expected).

Fields of papers citing papers by Shaimaa M. Badr-Eldin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaimaa M. Badr-Eldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaimaa M. Badr-Eldin. The network helps show where Shaimaa M. Badr-Eldin may publish in the future.

Co-authorship network of co-authors of Shaimaa M. Badr-Eldin

This figure shows the co-authorship network connecting the top 25 collaborators of Shaimaa M. Badr-Eldin. A scholar is included among the top collaborators of Shaimaa M. Badr-Eldin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaimaa M. Badr-Eldin. Shaimaa M. Badr-Eldin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khalek, Mohamed Abdel, et al.. (2025). Innovative Antimicrobial Nanofibers: Natural Integrations for Enhanced Wound Healing and Biofilm Disruption. AAPS PharmSciTech. 26(6). 181–181. 1 indexed citations

Badr-Eldin, Shaimaa M., Hibah M. Aldawsari, Osama A. A. Ahmed, et al.. (2024). Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa. Nanotechnology Reviews. 13(1). 9 indexed citations

Kotta, Sabna, et al.. (2023). Development and evaluation of quercetin enriched bentonite-reinforced starch-gelatin based bioplastic with antimicrobial property. Saudi Pharmaceutical Journal. 31(12). 101861–101861. 6 indexed citations

Badr-Eldin, Shaimaa M., Hibah M. Aldawsari, Nabil A. Alhakamy, et al.. (2022). Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics. 14(5). 1024–1024. 7 indexed citations

Abdel‐Naim, Ashraf B., Shaimaa M. Badr-Eldin, Zuhier Awan, et al.. (2022). Novel Nanoconjugate of Apamin and Ceftriaxone for Management of Diabetic Wounds. Life. 12(7). 1096–1096. 10 indexed citations

Alhakamy, Nabil A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, et al.. (2022). Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. Pharmaceutics. 14(2). 227–227. 11 indexed citations

Badr-Eldin, Shaimaa M., Hibah M. Aldawsari, Usama A. Fahmy, et al.. (2022). Optimized Apamin-Mediated Nano-Lipidic Carrier Potentially Enhances the Cytotoxicity of Ellagic Acid against Human Breast Cancer Cells. International Journal of Molecular Sciences. 23(16). 9440–9440. 12 indexed citations

Asfour, Hani Z., Nabil A. Alhakamy, Usama A. Fahmy, et al.. (2022). Zein-Stabilized Nanospheres as Nanocarriers for Boosting the Aphrodisiac Activity of Icariin: Response Surface Optimization and In Vivo Assessment. Pharmaceutics. 14(6). 1279–1279. 6 indexed citations

Alharbi, Waleed S., Mohamed A. Alfaleh, Nabil A. Alhakamy, et al.. (2022). Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics. 14(12). 2627–2627. 23 indexed citations

10.

Aldawsari, Hibah M., Sima Singh, Nabil A. Alhakamy, et al.. (2022). Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals. 15(5). 544–544. 13 indexed citations

11.

Ahmed, Osama A. A., Shaimaa M. Badr-Eldin, Giuseppe Caruso, et al.. (2022). Colon Targeted Eudragit Coated Beads Loaded with Optimized Fluvastatin-Scorpion Venom Conjugate as a Potential Approach for Colon Cancer Therapy: In Vitro Anticancer Activity and In Vivo Colon Imaging. Journal of Pharmaceutical Sciences. 111(12). 3304–3317. 3 indexed citations

12.

Kotta, Sabna, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, et al.. (2021). Lung Targeted Lipopolymeric Microspheres of Dexamethasone for the Treatment of ARDS. Pharmaceutics. 13(9). 1347–1347. 21 indexed citations

13.

Alhakamy, Nabil A., Usama A. Fahmy, Shaimaa M. Badr-Eldin, et al.. (2021). Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells. Polymers. 14(1). 93–93. 35 indexed citations

14.

Kotta, Sabna, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, et al.. (2021). Aerosol Delivery of Surfactant Liposomes for Management of Pulmonary Fibrosis: An Approach Supporting Pulmonary Mechanics. Pharmaceutics. 13(11). 1851–1851. 23 indexed citations

15.

Fahmy, Usama A., Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, et al.. (2020). The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells. Pharmaceutics. 12(10). 956–956. 22 indexed citations

16.

Alhakamy, Nabil A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, et al.. (2020). Piceatannol-Loaded Emulsomes Exhibit Enhanced Cytostatic and Apoptotic Activities in Colon Cancer Cells. Antioxidants. 9(5). 419–419. 34 indexed citations

17.

Ahmed, Osama A. A., Khalid M. El‐Say, Bader M. Aljaeid, Shaimaa M. Badr-Eldin, & Tarek A. Ahmed. (2018). Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies. International Journal of Nanomedicine. Volume 14. 33–43. 38 indexed citations

18.

Ahmed, Tarek A., Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, & Hibah M. Aldawsari. (2018). Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin. Journal of Drug Delivery Science and Technology. 48. 499–508. 47 indexed citations

19.

Ahmed, Osama A. A. & Shaimaa M. Badr-Eldin. (2018). In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance. International Journal of Nanomedicine. Volume 13. 6325–6335. 24 indexed citations

20.

Badr-Eldin, Shaimaa M., L K Trejdosiewicz, R V Heatley, & M S Losowsky. (1988). Local immunity in ulcerative colitis: evidence for defective secretory IgA production.. Gut. 29(8). 1070–1075. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact